Despite advances in disease prevention, coronary artery disease remains a major cause of illness and death in the United States. The costs of treating this disease and the indirect costs resulting from lost work and wages are substantial. The exercise, can be strenous or light, stress test is a useful tool for detecting coronary artery disease and for evaluating medical therapy and cardiac rehabilitation following myocardial infarction.

In addition to the standard exercise stress test, other methods of cardiovascular stress testing include scintigraphy and echocardiography.

Exercise stress scintigraphy uses a radioactive tracer to enhance abnormal areas of myocardial blood flow. Stress scintigraphy can be performed with pharmacologic agents instead of exercise if the patient's condition does not allow sufficient physical activity for performing the study. Echocardiography has recently been used in combination with exercise or pharmacologic stress testing as yet another form of noninvasive cardiac evaluation.

Competence and Equipment Requirements

The clinical competence to perform exercise stress testing is usually granted by staff privileges in health care institutions. The Joint Commission on Accreditation of Healthcare Organizations requires that institutions assess competence on the basis of criteria established in the medical staff bylaws. A combined specialty task force, composed of members from the American College of Cardiology (ACC), the American College of Physicians and the American Heart Association (AHA), in 1996 issued a statement on clinical competence in exercise testing. Exercise stress testing is appropriate in persons who plan to engage in vigorous exercise. In this situation, the test is recommended for use in women 50 years and older and in men 40 years and older.

Equipment requirements for exercise stress testing include a bicycle ergometer or treadmill, a monitor system, a medical crash cart and a defibrillator. Equipment costs can range from $15,000 to $40,000. Personnel requirements include the examiner and one other person trained in basic cardiac life support, although someone with advanced cardiac life support skills is preferred.

Sensitivity and Specificity

Exercise stress testing provides a controlled environment for observing the effects of increases in the myocardial demand for oxygen; significant fixed stenoses from coronary artery disease result in electrocardiographic (ECG) evidence of ischemia.

Particularly difficult to detect is evidence of fixed stenoses with collateral blood flow, as well as low-grade (less than 50 percent) stenoses. These abnormalities may not produce sufficient impairment of blood flow to affect the ECG. Some studies indicate that maybe low-grade stenoses are often the source of spontaneous thrombosis, leading to the sudden development of significant stenosis, infarction and sudden death because such lesions do not have the benefit of collateral blood flow.12 An exercise stress test would not be helpful in detecting this type of lesion.

The estimation of the pretest probability of a significant fixed stenosis should be based on the patient's age, gender, symptoms, concurrent medical conditions, medications and physical examination, as well as on the clinician's diagnostic experience with symptoms of myocardial ischemia. This information is helpful for determining the potential utility of an exercise stress test for a given patient.

The sensitivity of exercise stress testing ranges from 23 to 100 percent, and the specificity ranges from 17 to 100 percent. For example, in an abnormal exercise stress test in which a man reaches a heart rate of 85 percent of the predicted maximum for his age, the sensitivity and specificity for the diagnosis of significant coronary artery disease is 65 percent and 85 percent, respectively. A more detailed discussion of sensitivity, specificity, population effect and probability analysis is available in the ACC/AHA Task Force Report on exercise, can be strenous or light, Stress Testing.

Consideration may be given to obtaining this test when patients present with symptoms of coronary artery disease, including the classic anginal symptoms of chest pressure or pain that occurs with or without exertion. Atypical presentations or anginal equivalents, such as shortness of breath or dyspnea on exertion, are also appropriate indications for this study.

Conditions that may render a patient unable to exercise adequately during the stress test include claudication, severe physical disabilities and pulmonary disease.

Patients with coronary artery disease who have undergone surgical intervention or are receiving medical therapy can perform an exercise stress test when they are medically stable and symptom-free. The study can be used to assess the effectiveness of treatment. After myocardial infarction, patients may be candidates for exercise stress testing at a low level of exercise to determine functional capacity and identify any ECG changes or symptoms during exercise. With this information, the clinician is often able to prescribe an exercise regimen or more aggressive therapy, or to select the appropriate tests for further evaluation.

Asymptomatic healthy persons may be considered as candidates for exercise stress testing if they are in high-risk occupations (e.g., pilots, firefighters, law enforcement officers, mass transit operators). In addition, the American College of Sports Medicine (ACSM) recommends an exercise stress test for all women 50 years of age and older and all men 40 years of age and older who plan to engage in vigorous exercise. The ACSM does not recommend exercise stress testing for asymptomatic healthy persons who are not planning vigorous exercise, regardless of the person's age.

An exercise stress test may also be considered in asymptomatic patients who have two or more risk factors for coronary artery disease or a concurrent chronic disease, such as diabetes, that carries a high risk of coronary disease. Patients with valvular disorders (except those with hemodynamically significant aortic stenosis) may undergo an exercise stress test to evaluate their functional capacity, the effectiveness of treatment, their symptom complex or the need for surgical intervention.

Pretest Evaluation

The history, physical examination and laboratory studies necessary to evaluate the patient's suitability for performing an exercise stress test are summarized in Table. A baseline electrocardiogram must be evaluated for changes that might obscure the results of stress testing, such as significant ST-segment changes, ventricular strain patterns and conduction abnormalities.

In addition, the patient should receive the proper preparatory instructions for the exercise stress test as required by the hospital or the testing laboratory. Instructions usually include no food intake for six to 12 hours before the study. Patients should be told to wear loose-fitting, comfortable clothing and comfortable walking shoes. In addition, instructions about modifying the doses of any medications should be given.

History In addition to the presence and character of chest pain, concurrent medical conditions such as claudication, severe physical disabilities and pulmonary disease should be considered in view of their effects on the patient's ability to exercise. Such conditions may render the patient unable to perform the test. Exercise usually worsens uncontrolled hypertension, and the pretest evaluation may be terminated because of this finding.

The patient's general activity level and pulmonary reserve and the presence of arthritic disease may influence the type of exercise test protocol selected and the duration and level of activity achieved. Many exercise protocols exist to accommodate patients who need to walk at a slower pace or advance through exercise stages at a slower rate.

The patient's current medications are important. Nitrates may mask the occurrence of chest pain; beta-adrenergic blockers may blunt the heart rate response to exercise, and digoxin (Lanoxin) may produce abnormal ST-segment depression.

Physical Examination

A general physical examination with special attention usually is adequate for the pretest evaluation. Cardiac examination should include an assessment for the presence of murmurs and valvular disease. Severe valvular dysfunction, especially aortic stenosis, is an absolute contraindication to exercise stress testing. Gallop rhythms are noteworthy because the presence of an S3 may indicate significant congestive heart failure, a contraindication if it is clinically severe. While the development of an S4 during exercise may indicate significant cardiac ischemia, detection of it during a physical examination does not signify ischemia and is not grounds for not performing an exercise stress test.

An assessment of the vascular system should include palpation of the carotid and peripheral pulses, as well as evaluation for the presence of bruits over the abdominal aorta and other larger vessels. Because claudication of the lower extremities or transient ischemic attack­type symptoms can occur during exercise, another type of stress testing that does not require exercise should be considered if the physical examination suggests that these problems are clinically significant.

Assessment of the musculoskeletal system includes evaluation of the patient's ability to walk at a moderate to fast pace without significant gait disturbances. The hips, shoulders, arms and legs should allow relatively full mobility and support during exercise.

Laboratory Studies Screening laboratory studies are obtained to diagnose subclinical disease that may be present. Exercise stress testing should not be performed in patients with symptoms of anemia or severe hepatic, renal or metabolic disorders.

A resting ECG is an essential part of the pretest evaluation. The patient should have a resting ECG that is free of abnormalities. While the presence of any of these ECG changes is not an absolute contraindication to exercise stress testing, they may interfere with the validity of the test by altering the ECG changes that are consistent with ischemia during exercise. Most authorities suggest an imaging study in addition to exercise stress testing as a part of the cardiac evaluation in most patients with these changes on the baseline ECG. It should be noted, however, that in these persons, an exercise stress test could potentially be used to evaluate functional capacity, blood pressure response or other clinically determined parameters.

Potential Contraindications to Exercise Stress Testing

Absolute Contraindications

Exercise stress testing may worsen the patient's condition or place the patient at increased risk of cardiac instability or injury in the setting of acute myocardial infarction, unstable angina, acute cardiac inflammation, severe congestive heart failure, uncontrolled sustained ventricular arrhythmias, symptomatic supraventricular arrhythmia, high-grade block, hemodynamically significant aortic stenosis or severe hypertension. Patients with such conditions usually require immediate medical or surgical intervention as clinically indicated but may be reassessed as candidates for exercise stress testing when the acute problems are resolved. The remaining contraindications render the patient physically unable to perform an exercise stress test.

Relative contraindications to exercise stress testing. While patients with these conditions may undergo a standard exercise stress test, they require special consideration because the presence of these conditions may invalidate the test results.

In most cases, medications should not be withheld in preparation for an exercise stress test. Patients can be instructed to take their medications before an exercise stress test, with the exception of insulin and oral hypoglycemic agents. Depending on how stable the patient's diabetic condition is, all of the dose of insulin or the hypoglycemic agent or one half of the dose should be withheld before the test.

Digoxin may depress the ST-segments. If ST-segment depression of 1 mm or more is present on the baseline ECG, use of ECG criteria for exercise-induced ischemia during exercise will be difficult. Type I antiarrhythmic agents and tricyclic antidepressants are proarrhythmogenic. For example, if at baseline a patient receiving any one of these medications has significant ectopy, the patient is at increased risk of hemodynamically significant arrhythmias with exercise and should not undergo exercise stress testing.

The antihypertensive effect of beta blockers, alpha blockers and nitroglycerin may cause significant hypotension during exercise. In general, orthostatic blood pressure assessment and a careful history will identify most patients susceptible to such a response. Beta blockers may also blunt the heart rate during exercise. While patients receiving beta blockers may perform the exercise required for the test, the usual age-adjusted target heart rate may not be a realistic end point for them.

Most electrolyte and endocrinologic abnormalities can affect the heart rate and ST-segment and T-wave changes on a resting ECG, and they may affect the patient's ability to exercise as well. Vasoregulatory problems from central and peripheral autonomic neuropathy associated with disorders such as diabetes, Parkinson's disease and Shy-Drager's syndrome may cause profound vasodilation and hypotension during exercise. The pretest evaluation should alert the clinician to the presence of this tendency, and exercise stress testing should not be performed if such a response to exercise seems significant.

Patients who have a history of tachyarrhythmias may be considered candidates for exercise stress testing, but those with easily reproduced tachycardia during exercise or other heavy physical activity are not candidates for exercise stress testing. Such a problem may be found in patients with mitral valve prolapse syndrome, Wolff-Parkinson-White syndrome and episodic or periodic supraventricular tachycardia. The occurrence of a tachyarrhythmia during exercise stress testing could cause syncope or, at a minimum, produce an inconclusive result.

Most exercise stress tests are interpreted in a standard format that includes an interpretation (or comment) section and a conclusion. Each section may not be described in every report because some of them may not be relevant or particularly useful in every clinical circumstance. Systolic hypotension, a very significant finding during a stress test, can signify severe coronary artery disease.

An interpretation of the baseline ECG is included in the report, noting any abnormalities and changes that occurred with changes in position (standing, lying or sitting). Symptoms occurring during the exercise stress test are usually reported as well. Most commonly, these comments are described as "fatigue," "legs tired," "chest pain/pressure," "shortness of breath," etc. If these symptoms were severe, they may have been the reason for discontinuing the test. Other reasons cited for stopping the test may be "target heart rate achieved," "exercise stopped per patient's request," "equipment malfunction" or "ECG findings or criteria were met."

Also usually described are the duration of the exercise period and the workload in METS (metabolic equivalents, or resting oxygen consumption of about 3.5 mL per kg per minute). The interpreter may also add subjective comments about the patient's exercise capacity; for example, the report may state "poor exercise tolerance (3 to 4 METS)" or "good exercise tolerance (10 to 11 METS)." The cardiorespiratory fitness levels established by the ACSM can serve as general guidelines.

Increases or decreases in blood pressure during exercise and rest are also noted. Hypotension, defined as a drop of more than 10 mm Hg in the systolic blood pressure during exercise, may signify severe cardiac ischemia. Opinions vary as to the definition of a hypertensive response to exercise, can be strenous or light, , but most authorities accept as a maximal limit a systolic pressure of 230 mm Hg. The diastolic blood pressure during exercise usually varies 10 mm Hg in either direction. A 10 mm Hg decrease in the diastolic blood pressure during the postexercise period is not unusual and is considered physiologic.

While the presence of arrhythmias may or may not carry clinical significance, their frequency, type and appearance or disappearance with exercise and rest are also noted.

The final category of information provided in the report is the ECG response during exercise and recovery. Findings usually include the presence and location of ST-segment changes, P-wave, T-wave and U-wave changes, and the appearance of conduction abnormalities during the exercise and recovery periods.

Test Conclusions - Positive Results. An exercise stress test positive for myocardial ischemia may be further qualified with the terms "probably" and "strongly." For example, hypotension (a drop of more than 10 mm Hg in systolic pressure) or large (more than 2 to 3 mm) ST-segment depressions, either alone or in combination, are strongly positive test results. The presence of these abnormalities leaves little clinical doubt that significant coronary artery disease exists. The appearance during exercise of an S3, S4 or murmur indicates cardiac muscle dysfunction and therefore ischemia. The interpreter may also comment on the recovery or return to baseline of these findings as well as any interventions needed to bring about this change.

Negative Results. A negative test result is simply the lack of any of the above-mentioned findings. Some normal physiologic and ECG changes may occur during exercise.

Electrocardiographic (ECG) findings suggestive of a positive exercise(heavy or light physical exertions) stress test. In addition to the ECG findings depicted here, the occurrence of frequent premature ventricular contractions (PVCs), multifocal PVCs or ventricular tachycardia at mild exercise (less than 70 percent of maximal heart rate) is suggestive of an exercise stress test positive for myocardial ischemia.

Equivocal, or Inconclusive, Findings. Equivocal exercise stress test results are summarized in Table 10. These ECG changes are not diagnostic of ischemia. Alterations in the P-wave and T-wave morphology and changes in atrioventricular conduction with exercise are considered nondiagnostic if the changes revert to baseline in the rest period. The appearance of unifocal, premature atrial contractions or premature ventricular contractions (fewer than five per minute) is not a specific indicator for coronary artery disease. The development of intraventricular blocks, such as right bundle branch block, left bundle branch block and hemiblocks, is a nondiagnostic finding. An intraventricular block may also obscure ischemic changes and hinder further interpretation of the ECG. As with all inconclusive results, additional testing is needed. In most cases, an imaging study, exercise scintigraphy or echocardiography is needed to document ischemia.

Uninterpretable Results. In addition to equipment failure, other causes of uninterpretable test results include the patient's or operator's inability to complete the test before any goals are met. Further diagnostic studies should be planned, and any information that could have contributed to this result should be included in the report. For example, the patient may have appeared on physical examination to be a good exercise candidate but was unable or unwilling to comply with the requirements of the exercise stress test. In this case, the reason for noncompliance can help the clinician choose another examination that would be more appropriate for the patient.

Maximal and Submaximal Exercise Stress Test. A maximal exercise stress test is one that achieves the target heart rate, exercise level or time limit established for the patient. In most cases, the goal is the target heart rate, as calculated with the following formula: (220 - patient's age) × 0.85 beats per minute. An exercise stress test that does not meet the expected goal is called a submaximal study. If the stress test is submaximal because of decreased exercise capacity or noncardiac symptoms, consideration should be given to obtaining radionuclide scintigraphy or echocardiographic studies that do not include exercise as a component of the evaluation.

Antihistamines
Histamine is an important body chemical that is responsible for the congestion, sneezing, and runny nose that a patient suffers with an allergic attack or an infection. Antihistamine drugs block the action of histamine, therefore reducing the allergy symptoms. For the best result, antihistamines should be taken before allergic symptoms get well established.

The most annoying side effect that antihistamines produce is drowsiness. Though desirable at bedtime, it is a nuisance to many people who need to use antihistamines in the daytime. To some people, it is even hazardous. These drugs are not recommended for daytime use for people who may be driving an automobile or operating equipment that could be dangerous. Newer non-sedating antihistamines, available by prescription only, do not have this effect. The first few doses cause the most sleepiness; subsequent doses are usually less troublesome.

Typical antihistamines include Allegra®, Benadryl®, Chlor-Trimetron,®, Claritin®, Clarinex®, Teldrin®, Zyrtec,® etc.

Decongestants, on the other hand, cause constriction or tightening of the blood vessels in those membranes, which then forces much of the blood out of the membranes so that they shrink, and the air passages open up again.

Decongestants are chemically related to adrenalin, the natural decongestant, which is also a type of stimulant. Therefore, the side effect of decongestants is a jittery or nervous feeling. They can cause difficulty in going to sleep, and they can elevate blood pressure and pulse rate. Decongestants should not be used by a patient who has an irregular heart rhythm (pulse), high blood pressure, heart disease, or glaucoma. Some patients taking decongestants experience difficulty with urination. Furthermore, decongestants are often used as ingredients in diet pills. To avoid excessively stimulating effects, patients taking diet pills should not take decongestants.

Typical decongestants are phenylephrine (Neo-Synephrine®*), and pseudoephedrine (Sudafed®, etc.)

* May be available over–the–counter without a prescription. Read labels carefully, and use only as directed.

Combination Remedies
Theoretically, if the side effects could be properly balanced, the sleepiness sometimes caused by antihistamines could be cancelled by the stimulation of decongestants. Numerous combinations of antihistamines with decongestants are available: Actifed,®* Allegra-D,® Chlor-Trimeton D,®* Claritin D,® Contac,®* Co-Pyronil 2,®* Deconamine,® Demazin,®* Dimetapp,®* Drixoral,®* Isoclor,®* Nolamine,® Novafed A,® Ornade,® Sudafed Plus,® Tavist D,®* Triaminic,®* and Trinalin,® to name just a few.

A patient may find one preparation quite helpful for several months or years but may need to switch to another one when the first loses its effectiveness. Since no one reacts exactly the same as another to the side effects of these drugs, a patient may wish to try his own ideas on adjusting the dosages. One might take the antihistamine only at night and take the decongestant alone in the daytime. Or take them together, increasing the dosage of antihistamine at night (while decreasing the decongestant dose) and then doing the opposite for daytime use.

Nose Sprays
The types of nose sprays that can be purchased without a prescription usually contain decongestants for direct application to nasal membranes. They can give prompt relief from congestion by constricting blood vessels. However, direct application creates a stronger stimulation than decongestants taken by mouth. It also impairs the circulation in the nose, which after a few hours, stimulates the vessels to expand to improve the blood flow again. This results in a "bounce-back" effect. The congestion recurs. If the patient uses the spray again, it starts the cycle again. Spray–decongestion– rebound–and more congestion.

In infants, this rebound rhinitis can develop in two days, whereas in adults, it often takes several more days to become established. An infant taken off the drops for 12 to 24 hours is cured, but well-established cases in adults often require more than a simple "cold turkey" withdrawal. They need decongestants by mouth, sometimes corticosteroids, and possibly (in patients who continuously have used the sprays for months and years) a surgical procedure to the inside of the nose. For this reason, the labels on these types of nose sprays contain the warning "Do not use this product for more than three days." Nose sprays should be reserved for emergency and short term use.